A research peptide combination featuring CJC and Ipamorelin without DAC. It is studied for its interaction with growth hormone–related signaling pathways and provides a useful model for investigating peptide-receptor activity and endocrine signaling.
Not for human consumption
CJC/IPA (No Dac) is a research peptide combination consisting of CJC-related peptide technology and Ipamorelin, formulated without DAC. It is investigated as a laboratory research material for studying peptide interactions with pathways associated with growth-hormone-related signaling and receptor activity.
The combination provides a useful research model for examining peptide-receptor interactions, signaling dynamics, structure-activity relationships, and endocrine-related molecular pathways. Researchers may use CJC/IPA (No Dac) to investigate the pharmacological characteristics of peptide combinations and their behavior under controlled experimental conditions.
You must be at least 21 years old to access The Research Peptides.
All products are sold strictly for in-vitro laboratory research use only.